Skip to content

Drug interactions

Panobinostat + Sotalol

Severity: Contraindicated

Panobinostat and Sotalol: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Panobinostat prolongs the QT interval and its labeling does not recommend use with other QT-prolonging drugs. Sotalol adds both QT prolongation and bradycardia, increasing the risk of torsades de pointes.

What this interaction means in plain words

Panobinostat and Sotalol are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Panobinostat belongs to Oncology; Sotalol belongs to Cardiovascular.

Evidence level: High

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Do not combine; use an alternative antiarrhythmic or rate control strategy during panobinostat treatment. If it cannot be avoided, seek specialist input and monitor ECG and electrolytes closely.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Panobinostat and Sotalol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Panobinostat with Sotalol?

MediHelp rates the interaction as contraindicated. Panobinostat and Sotalol are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Panobinostat prolongs the QT interval and its labeling does not recommend use with other QT-prolonging drugs. Sotalol adds both QT prolongation and bradycardia, increasing the risk of torsades de pointes.

How serious is the interaction between Panobinostat and Sotalol?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not combine; use an alternative antiarrhythmic or rate control strategy during panobinostat treatment. If it cannot be avoided, seek specialist input and monitor ECG and electrolytes closely.

What other medicines interact with Sotalol?

MediHelp also lists interactions of Sotalol with, for example, Arsenic trioxide, Artemether / lumefantrine, Disopyramide. The full list is on the Sotalol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in